| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02118727 | Amyotrophic Lateral Sclerosis|Frontal Temporal Dementia | Drug: Memantine|Drug: Placebo (for Memantine) | University of Kansas Medical Center | Phase 2 | 2017-07-01 | 2017-01-23 |
| NCT02015312 | Light Chain (AL) Amyloidosis|Cardiac Involvement | Drug: Epigallocatechin-3-gallate (EGCG)|Drug: Placebo | Florian Michel|German Federal Ministry of Education and Research|University Hospital Heidelberg | Phase 2 | 2013-04-01 | 2016-12-09 |
| NCT02879136 | Parkinson's Disease, Idiopathic | Drug: Methylphenidate|Other: Physical Therapy|Drug: Atomoxetine | Shnehal Patel|The Cleveland Clinic | Early Phase 1 | 2016-12-01 | 2017-01-09 |
| NCT02554435 | Physical Activity | Device: EAM|Behavioral: 5 A's counseling|Device: Pedometer | The University of Texas Medical Branch, Galveston|American Heart Association | | 2016-01-01 | 2016-09-12 |
| NCT02656017 | Polycystic Kidney, Autosomal Dominant | Drug: Metformin|Other: Placebo | University of Pittsburgh|Tufts Medical Center|University of Maryland|University of Southern California|United States Department of Defense | Phase 2 | 2016-05-01 | 2017-02-01 |
| NCT01020331 | Amyotrophic Lateral Sclerosis | Drug: Memantine | Phoenix Neurological Associates, LTD|Forest Laboratories | Phase 2 | 2005-06-01 | 2009-11-23 |
| NCT01820130 | Heart Failure | Device: St Jude Medical EON mini rechargeable system | St. Jude Medical | | 2013-03-01 | 2015-10-26 |
| NCT01027039 | Glaucoma | | Wills Eye | | 2008-06-01 | 2016-11-08 |
| NCT01938027 | Rectal Cancer | Procedure: Transanal total mesorectal excision | National Cancer Center, Korea | | 2013-09-01 | 2015-03-25 |
| NCT02932657 | Cystic Fibrosis | Other: Non interventional study | Nantes University Hospital | | 2017-05-01 | 2017-02-28 |
